JP2024536413A - 二環式ペプチドリガンド薬物コンジュゲート - Google Patents

二環式ペプチドリガンド薬物コンジュゲート Download PDF

Info

Publication number
JP2024536413A
JP2024536413A JP2024521039A JP2024521039A JP2024536413A JP 2024536413 A JP2024536413 A JP 2024536413A JP 2024521039 A JP2024521039 A JP 2024521039A JP 2024521039 A JP2024521039 A JP 2024521039A JP 2024536413 A JP2024536413 A JP 2024536413A
Authority
JP
Japan
Prior art keywords
drug conjugate
acid
peptide
peptide ligand
linker
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024521039A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023057758A5 (https=
JP2024536413A5 (https=
Inventor
ベスウィック,ポール
マッド,ジェマ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BicycleTx Ltd
Original Assignee
BicycleTx Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BicycleTx Ltd filed Critical BicycleTx Ltd
Publication of JP2024536413A publication Critical patent/JP2024536413A/ja
Publication of JPWO2023057758A5 publication Critical patent/JPWO2023057758A5/ja
Publication of JP2024536413A5 publication Critical patent/JP2024536413A5/ja
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP2024521039A 2021-10-06 2022-10-06 二環式ペプチドリガンド薬物コンジュゲート Pending JP2024536413A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB2114279.9A GB202114279D0 (en) 2021-10-06 2021-10-06 Bicyclic peptide ligand drug conjugates
GB2114279.9 2021-10-06
PCT/GB2022/052524 WO2023057758A1 (en) 2021-10-06 2022-10-06 Bicyclic peptide ligand drug conjugates

Publications (3)

Publication Number Publication Date
JP2024536413A true JP2024536413A (ja) 2024-10-04
JPWO2023057758A5 JPWO2023057758A5 (https=) 2025-10-15
JP2024536413A5 JP2024536413A5 (https=) 2025-10-15

Family

ID=78497713

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024521039A Pending JP2024536413A (ja) 2021-10-06 2022-10-06 二環式ペプチドリガンド薬物コンジュゲート

Country Status (6)

Country Link
US (1) US20240398965A1 (https=)
EP (1) EP4412657A1 (https=)
JP (1) JP2024536413A (https=)
CN (1) CN118215505A (https=)
GB (1) GB202114279D0 (https=)
WO (1) WO2023057758A1 (https=)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
DK1844337T3 (da) 2005-01-24 2013-09-30 Pepscan Systems Bv Bindingsforbindelser, immunogene forbindelser og peptidmimetika
AU2009211253B2 (en) 2008-02-05 2014-11-06 Bicyclerd Limited Methods and compositions
JP6882978B2 (ja) 2014-10-29 2021-06-02 バイスクルアールディー・リミテッド Mt1−mmpに特異的な二環性ペプチドリガンド
IL279489B2 (en) * 2018-06-22 2025-10-01 Bicycletx Ltd Bicyclic peptide ligands specific for nectin-4, a drug conjugate containing the peptide ligands and a pharmaceutical composition containing the drug conjugate
GB201914872D0 (en) * 2019-10-15 2019-11-27 Bicycletx Ltd Bicyclic peptide ligand drug conjugates

Also Published As

Publication number Publication date
US20240398965A1 (en) 2024-12-05
EP4412657A1 (en) 2024-08-14
CN118215505A (zh) 2024-06-18
GB202114279D0 (en) 2021-11-17
WO2023057758A1 (en) 2023-04-13

Similar Documents

Publication Publication Date Title
JP7682852B2 (ja) EphA2に特異的な二環式ペプチドリガンド
JP7404241B2 (ja) EphA2に特異的な二環ペプチドリガンド
US20240173422A1 (en) Bicyclic peptide ligand drug conjugates
EP3452096B1 (en) Bicyclic peptide-toxin conjugates specific for mt1-mmp
JP2025020121A (ja) Pd-l1に特異的な二環式ペプチドリガンド
JP2025011099A (ja) Psmaに特異的な二環式ペプチドリガンド
RU2708459C2 (ru) Бициклические пептидные лиганды, специфичные для мт1-ммр
CN113383007A (zh) Caix特异性的双环肽配体
JP2025023938A (ja) Cd38に特異的な二環式ペプチドリガンド
JP2024536413A (ja) 二環式ペプチドリガンド薬物コンジュゲート
US20240408219A1 (en) Bicyclic peptide ligand drug conjugates
US20230021419A1 (en) Bicyclic peptide ligands specific for il-17
RU2824959C2 (ru) Бициклические пептидные лиганды, специфичные для mt1-mmp

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251003

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251003